|
|||||
|
|
Tumor cell-intrinsic RIG-I signaling governs synergistic effects of immunogenic cancer therapies and checkpoint inhibitors in mice |
|
| Authors: | Hendrik Poeck Alexander Wintges Sarah Dahl Florian Bassermann Tobias Haas Simon Heidegger |
| Affiliation: | 1. Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany;2. Department of Medicine III, School of Medicine, Technical University of Munich, Munich, Germany;3. Department of Medicine III, School of Medicine, Technical University of Munich, Munich, Germany Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich, Germany |
| Abstract: | |
| Keywords: | Cancer immunotherapy Checkpoint inhibitors Epigenetic therapy Nucleic acid receptors RIG-I |